Effect of substance P on the 5,7-dihydroxytryptamine induced alteration of the postnatal development of central serotonin neurons.
Systemic treatment with the serotonin neurotoxin 5,7-dihydroxytryptamine [5,7-HT]in the neonatal stage leads to a permanent alteration of the postnatal development of the serotonin neurons in rat brain with denervation of distant nerve terminal projections and hyperinnervation in regions close to the serotonin perikarya. Intracisternal administration of substance P was found to counteract both the denervation and the hyperinnervation, as evaluated by measuring endogenous serotonin levels and [3H]-serotonin uptake in vitro. Furthermore, substance P was found to potentiate the reduction of serotonin induced by tryptophan hydroxylase inhibition with alpha-propyldopacetamide, indicating that substance P can produce an increase in serotonin utilization and turnover. The results suggest that substance P has a degeneration preventing and/or regrowth stimulatory effect on damaged serotonin neurons during ontogeny.
D015116:5,7-Dihydroxytryptamine / Q000494:pharmacology*; D000577:Amides / Q000494:pharmacology; D000818:Animals; D000831:Animals, Newborn; D001921:Brain / Q000187:drug effects / Q000502:physiology; D004102:Dihydroxytryptamines / Q000494:pharmacology*; D009410:Nerve Degeneration / Q000187:drug effects; D009474:Neurons / Q000187:drug effects* / Q000502:physiology; D051381:Rats; D013373:Substance P / Q000494:pharmacology*
D000577:Amides; D004102:Dihydroxytryptamines; C100072:dihydroxyphenylvaleramide; D015116:5,7-Dihydroxytryptamine; D013373:Substance P